Peripheral T-Cell Lymphoma-TBX21 — Rankings

Peripheral T-Cell Lymphoma-TBX21 — Rankings · CancerIndex

Rankings

Why this rank?

2 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Publications, last 12 months	World · both sexes · all ages · latest · all malignant entities	#1352 / 2,294	=	4 count	41.1	Medium confidence	ci-pubs-12m-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 12m counter publicationCount12m computedAt 2026-09-30T06:00:02.308Z inputs hash b1963bee32e72b8b6e51efec Trace lineage (admin)
Publications, last 5 years	World · both sexes · all ages · latest · all malignant entities	#1651 / 2,873	=	12 count	42.5	Medium confidence	ci-pubs-5y-v1	Sep 30, 2026	show formula: literature_counts.count WHERE window_key = 5y (query stored per row) counter publicationCount5y computedAt 2026-09-30T06:00:02.308Z inputs hash 7b01855837dd178dff17a0c3 Trace lineage (admin)

Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.

"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.

Why this rank?

Research gap